Company Data
Acumen Pharmaceuticals Inc.
Ticker
ABOS
Current Price
$2.92 -3.63%
Market Cap
$211.2M
Price Target
Refer to Report
Volume
305.8K
52wk Range
$1.21 - $3.6
Overview
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer’s disease. The company’s lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.